Pivotal phase III trial of ezatiostat for low to intermediate-1 risk myelodysplastic syndromes.
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2013
At a glance
- Drugs Ezatiostat (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- Sponsors Telik
- 15 Mar 2013 Telik needs to secure funding through the establishment of a corporate partnership and licensing agreement, funding from a non-profit agency, or other financing source, in order to initiate this trial, according to a company media release.
- 27 Jan 2013 New trial record